Vanda – V3 Media

News

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" and NEJM Evidence

April 30, 2026

/PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of the original research article titled “Efficacy and Safety of Imsidolimab for Generalized…

Tag: Vanda

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" and NEJM Evidence

THINK OUT OF THE BOX

WHO WE ARE

WHAT WE DO

Our Publication Site

Our Webinar Promotion Website

QUICK LINKS